Axogen, Inc. — Director's Dealing 2025

Nov 7, 2025

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Axogen, Inc. (AXGN)
CIK: 0000805928
Period of Report: 2025-11-05

Reporting Person: Burke William P. Mr. (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2025-11-05	Common Stock	M	11431	$8.14	Acquired	11531	Direct
2025-11-05	Common Stock	S	11431	$24.048	Disposed	100	Direct
2025-11-06	Common Stock	M	5347	$8.14	Acquired	5447	Direct
2025-11-06	Common Stock	S	5347	$24.008	Disposed	100	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2025-11-05	Stock Option (right to purchase)	$8.14	M	11431	Disposed	2032-07-11	Common Stock (11431)	Direct
2025-11-06	Stock Option (right to purchase)	$8.14	M	5347	Disposed	2032-07-11	Common Stock (5347)	Direct

Footnotes

F1: The sale reported on this Form 4 was made pursuant to a Rule 10b5-1(c) trading plan adopted March 14, 2025. The price reported in column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $24.00 to $24.25 per share. The Reporting Person hereby undertakes to provide upon request by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price.

F2: The sale reported on this Form 4 was made pursuant to a Rule 10b5-1(c) trading plan adopted March 14, 2025. The price reported in column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $24.00 to $24.06 per share. The Reporting Person hereby undertakes to provide upon request by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price.

F3: This grant vested in three equal annual installments on the annual anniversary of the grant date, July 11, 2022.